ifosfamide has been researched along with Magnesium Deficiency in 2 studies
Magnesium Deficiency: A nutritional condition produced by a deficiency of magnesium in the diet, characterized by anorexia, nausea, vomiting, lethargy, and weakness. Symptoms are paresthesias, muscle cramps, irritability, decreased attention span, and mental confusion, possibly requiring months to appear. Deficiency of body magnesium can exist even when serum values are normal. In addition, magnesium deficiency may be organ-selective, since certain tissues become deficient before others. (Harrison's Principles of Internal Medicine, 12th ed, p1936)
| Excerpt | Relevance | Reference |
|---|---|---|
| " Nephrotoxicity is a known side effect of several treatments, including cisplatin, carboplatin, ifosfamide, radiotherapy and nephrectomy, and can cause glomerular filtration rate (GFR) impairment, proteinuria, tubulopathy, and hypertension." | 5.01 | Early and late adverse renal effects after potentially nephrotoxic treatment for childhood cancer. ( Bökenkamp, A; Kooijmans, EC; Tettero, JM; Tjahjadi, NS; van der Pal, HJ; van Dulmen-den Broeder, E; Veening, MA, 2019) |
| " Nephrotoxicity is one of these known (acute) side effects of several treatments, including cisplatin, carboplatin, ifosfamide, radiotherapy and nephrectomy, and can cause glomerular filtration rate impairment, proteinuria, tubulopathy and hypertension." | 4.89 | Early and late renal adverse effects after potentially nephrotoxic treatment for childhood cancer. ( Blufpand, H; Bökenkamp, A; Jaspers, MW; Knijnenburg, SL; Kremer, LC; Mulder, RL; Schouten-Van Meeteren, AY; van Dulmen-den Broeder, E; Veening, MA, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kooijmans, EC | 1 |
| Bökenkamp, A | 2 |
| Tjahjadi, NS | 1 |
| Tettero, JM | 1 |
| van Dulmen-den Broeder, E | 2 |
| van der Pal, HJ | 1 |
| Veening, MA | 2 |
| Knijnenburg, SL | 1 |
| Mulder, RL | 1 |
| Schouten-Van Meeteren, AY | 1 |
| Blufpand, H | 1 |
| Kremer, LC | 1 |
| Jaspers, MW | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy of Oral Supplementation With Magnesium to Reduce Febrile Neutropenia in Pediatric Oncology Patients Treated With Cisplatin-Based Chemotherapy: Randomized Clinical Trial[NCT03449693] | Phase 2 | 214 participants (Anticipated) | Interventional | 2017-10-19 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for ifosfamide and Magnesium Deficiency
| Article | Year |
|---|---|
Early and late adverse renal effects after potentially nephrotoxic treatment for childhood cancer.
Topics: Adult; Antineoplastic Agents; Carboplatin; Child; Cisplatin; Glomerular Filtration Rate; Humans; Hyp | 2019 |
Early and late renal adverse effects after potentially nephrotoxic treatment for childhood cancer.
Topics: Adult; Antineoplastic Agents; Carboplatin; Child; Cisplatin; Glomerular Filtration Rate; Humans; Hyp | 2013 |